GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » Change In Other Working Capital

UPB (Upstream Bio) Change In Other Working Capital : $-0.25 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Upstream Bio Change In Other Working Capital?

Upstream Bio's Change In Other Working Capital for the quarter that ended in Mar. 2025 was $-0.13 Mil. It means Upstream Bio's Other Working Capital declined by $0.13 Mil from Dec. 2024 to Mar. 2025 .

Upstream Bio's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $-0.13 Mil. It means Upstream Bio's Other Working Capital declined by $0.13 Mil from Dec. 2023 to Dec. 2024 .


Upstream Bio Change In Other Working Capital Historical Data

The historical data trend for Upstream Bio's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Upstream Bio Change In Other Working Capital Chart

Upstream Bio Annual Data
Trend Dec22 Dec23 Dec24
Change In Other Working Capital
-0.07 -0.08 -0.13

Upstream Bio Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial -0.02 -0.02 0.02 -0.11 -0.13

Upstream Bio Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Upstream Bio Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Upstream Bio's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Upstream Bio Business Description

Industry
Traded in Other Exchanges
N/A
Address
890 Winter Street, Suite 200, Waltham, MA, USA, 02451
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.